Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof

Patent No. EP2651400 (titled "Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof") was filed by Amgen Europe on Dec 15, 2011. The application was issued on Jan 18, 2023.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
TEVA PHARMACEUTICALS	May 6, 2020	D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Dec 22, 2022
Decision to maintain the European patent in amended form
Dec 22, 2022
Decision to maintain the European patent in amended form
Dec 16, 2022
Termination of the opposition proceedings with maintenance of patent
Dec 8, 2022
(Electronic) Receipt
Dec 8, 2022
Filing of the translation of the amended claims
Dec 8, 2022
French translation of claims
Dec 8, 2022
German translation of the claims
Dec 8, 2022
Letter accompanying subsequently filed items
Aug 30, 2022
Communication of bibliographic data
Aug 30, 2022
Communication to opponent concerning maintenance
Aug 30, 2022
Communication with request to file translations
Aug 25, 2022
Maintenance of the patent with the documents specified in the final decision
May 25, 2022
(Electronic) Receipt
May 25, 2022
Advice of delivery
May 25, 2022
Letter accompanying subsequently filed items
May 24, 2022
Advice of delivery
May 16, 2022
Decision of the Opposition Division and instruction
May 16, 2022
Druckexemplar in opposition procedure
May 16, 2022
Grounds for the decision (Annex) - opposition
May 16, 2022
Interlocutory decision in opposition proceedings
May 16, 2022
Interlocutory decision in opposition proceedings
May 16, 2022
Means of redress
May 16, 2022
Transmittal of decision / summons - opposition
May 16, 2022
Transmittal of decision / summons - opposition
Mar 8, 2022
Notification concerning the date of oral proceedings
Mar 8, 2022
Notification concerning the date of oral proceedings
Mar 1, 2022
Brief communication - Opposition proceedings
Feb 24, 2022
(Electronic) Receipt
Feb 24, 2022
Letter accompanying subsequently filed items
Feb 24, 2022
Written submission in preparation to/during oral proceedings
Feb 21, 2022
Notification concerning the date of oral proceedings
Feb 21, 2022
Notification concerning the date of oral proceedings
Feb 7, 2022
Brief communication - Opposition proceedings
Feb 2, 2022
Brief communication - Opposition proceedings
Jan 31, 2022
(Electronic) Receipt
Jan 31, 2022
Letter accompanying subsequently filed items
Jan 31, 2022
Written submission in preparation to/during oral proceedings
Jan 28, 2022
Request for interpreters during oral proceedings
Dec 10, 2021
Notification concerning the date of oral proceedings
Dec 10, 2021
Notification concerning the date of oral proceedings
Oct 19, 2021
Communication of amended entries
Oct 8, 2021
Letter accompanying subsequently filed items
Oct 8, 2021
Request for a change of address - opponent
Apr 14, 2021
(Electronic) Receipt
Apr 14, 2021
Advice of delivery
Apr 14, 2021
Letter accompanying subsequently filed items
Apr 9, 2021
Annex to the communication - opposition
Apr 9, 2021
Information concerning oral proceedings
Apr 9, 2021
Summons to attend oral proceedings
Apr 9, 2021
Summons to attend oral proceedings
Apr 9, 2021
Transmittal of decision / summons - opposition
Apr 9, 2021
Transmittal of decision / summons - opposition
Mar 29, 2021
Scanned annex to a communication - opposition procedure
Jan 15, 2021
Brief communication - Opposition proceedings
Dec 23, 2020
(Electronic) Receipt
Dec 23, 2020
Any annexes (other than citation) to an opposition letter
Dec 23, 2020
Auxiliary request during Opposition procedure
Dec 23, 2020
Auxiliary request during Opposition procedure
Dec 23, 2020
Auxiliary request during Opposition procedure
Dec 23, 2020
Auxiliary request during Opposition procedure
Dec 23, 2020
Auxiliary request during Opposition procedure
Dec 23, 2020
Auxiliary request during Opposition procedure - 01
Dec 23, 2020
Auxiliary request during Opposition procedure - 02
Dec 23, 2020
Auxiliary request during Opposition procedure - 03
Dec 23, 2020
Auxiliary request during Opposition procedure - 04
Dec 23, 2020
Auxiliary request during Opposition procedure - 05
Dec 23, 2020
Letter accompanying subsequently filed items
Dec 23, 2020
Letter regarding the opposition procedure (no time limit)
Dec 23, 2020
Reply of the patent proprietor to the notice(s) of opposition
Sep 15, 2020
Brief communication - Opposition proceedings
Sep 15, 2020
Grant of extension of time limit (opposition procedure)
Sep 11, 2020
Brief communication - Opposition proceedings
Sep 11, 2020
Communication of the registration of a transfer or change of name and/or address
Sep 9, 2020
(Electronic) Receipt
Sep 9, 2020
Letter accompanying subsequently filed items
Sep 9, 2020
Request for extension of time limit
Sep 3, 2020
(Electronic) Receipt
Sep 3, 2020
Annexes in respect of a client data request
Sep 3, 2020
Consolidated list of cited opposition documents
Sep 3, 2020
Letter accompanying subsequently filed items
Sep 3, 2020
Submission concerning a transfer of rights (proprietor)
Jun 18, 2020
Communication of a notice of opposition and request to file observations
Jun 18, 2020
Notice of further oppositions to opponent(s)
May 12, 2020
Communication of a notice of opposition - first information to patent proprietor
May 6, 2020
(Electronic) Receipt
May 6, 2020
Citation in opposition procedure - 001
May 6, 2020
Citation in opposition procedure - 002
May 6, 2020
Citation in opposition procedure - 003
May 6, 2020
Citation in opposition procedure - 004
May 6, 2020
Citation in opposition procedure - 005
May 6, 2020
Citation in opposition procedure - 006
May 6, 2020
Citation in opposition procedure - 007
May 6, 2020
Citation in opposition procedure - 008
May 6, 2020
Citation in opposition procedure - 009
May 6, 2020
Citation in opposition procedure - 010
May 6, 2020
Citation in opposition procedure - 011
May 6, 2020
Citation in opposition procedure - 012
May 6, 2020
Notice of opposition
May 6, 2020
Notice of opposition
Jan 21, 2020
Communication of amended entries concerning the representative
Aug 19, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 11, 2019
Decision to grant a European patent
Jul 11, 2019
Decision to grant a European patent
Jun 27, 2019
Bibliographic data of the European patent application
Jun 27, 2019
Information about intention to grant a patent
Jun 27, 2019
Intention to grant (signatures)
Jun 27, 2019
Text intended for grant (clean copy)
Jun 27, 2019
Text intended for grant (version for approval)
May 28, 2019
(Electronic) Receipt
May 28, 2019
Amended claims with annotations
May 28, 2019
Claims
May 28, 2019
French translation of claims
May 28, 2019
German translation of the claims
May 28, 2019
Letter accompanying subsequently filed items
May 28, 2019
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Jan 29, 2019
Bibliographic data of the European patent application
Jan 29, 2019
Communication about intention to grant a European patent
Jan 29, 2019
Intention to grant (signatures)
Jan 29, 2019
Text intended for grant (clean copy)
Jan 29, 2019
Text intended for grant (version for approval)
Jan 3, 2019
(Electronic) Receipt
Jan 3, 2019
Amended claims with annotations
Jan 3, 2019
Claims
Jan 3, 2019
Description
Jan 3, 2019
Drawings
Jan 3, 2019
Letter accompanying subsequently filed items
Jan 3, 2019
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Aug 28, 2018
Bibliographic data of the European patent application
Aug 28, 2018
Communication about intention to grant a European patent
Aug 28, 2018
Intention to grant (signatures)
Aug 28, 2018
Text intended for grant (clean copy)
Aug 28, 2018
Text intended for grant (version for approval)
Apr 11, 2017
(Electronic) Receipt
Apr 11, 2017
Amended claims with annotations
Apr 11, 2017
Claims
Apr 11, 2017
Letter accompanying subsequently filed items
Apr 11, 2017
Reply to communication from the Examining Division
Mar 1, 2017
Annex to the communication
Mar 1, 2017
Communication from the Examining Division
Nov 25, 2015
(Electronic) Receipt
Nov 25, 2015
Annex
Nov 25, 2015
Claims
Nov 25, 2015
Letter accompanying subsequently filed items
Nov 25, 2015
Reply to communication from the Examining Division
Jul 21, 2015
Annex to the communication
Jul 21, 2015
Communication from the Examining Division
Jul 15, 2015
Examination started
Jan 24, 2014
(Electronic) Receipt
Jan 24, 2014
Amended claims filed after receipt of (European) search report
Jan 24, 2014
Amended claims with annotations
Jan 24, 2014
Amendments received before examination
Jan 24, 2014
Letter accompanying subsequently filed items
Sep 25, 2013
Notification on forthcoming publication of bibliographic data
Jul 24, 2013
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Jul 22, 2013
Communication to designated inventor
Jul 22, 2013
Communication to designated inventor
Jul 22, 2013
Communication to designated inventor
Jul 10, 2013
(Electronic) Receipt
Jul 10, 2013
Amended claims filed after receipt of (European) search report
Jul 10, 2013
Request for entry into the European phase
Jul 3, 2013
Copy of the international preliminary report on patentability
Apr 26, 2013
Information on entry into European phase
Apr 23, 2013
Notification of the recording of a change
Aug 23, 2012
Copy of the international search report
Aug 23, 2012
International publication of the international search report
Jul 10, 2012
Priority document (electronically transmitted)
Jul 10, 2012
Written opinion of the ISA, boxes No. I to VIII
Jul 10, 2012
Written opinion of the ISA, cover sheet
Jul 10, 2012
Written opinion of the ISA, supplemental box
Jun 21, 2012
Published international application - A2
Jan 13, 2012
Abstract
Jan 13, 2012
Claims
Jan 13, 2012
Description
Jan 13, 2012
Drawings

EP2651400

AMGEN EUROPE

Application Number: EP11831805A
Filing Date: Dec 15, 2011
Status: Patent Maintained As Amended; Dec 16, 2022
Publication Date: Jan 18, 2023
External Links: Slate, Register , Google Patents

IP Verse

Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2651400